| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.16 | 0.002 |